A company which has developed a clinical operating system and electronic health record has raised 拢6.2 million to further expand in the UK and fuel future international expansion.
Heydoc鈥檚 Series A round was led by Smedvig Capital with existing investors Hambro Perks, Triple Point鈥疺entures鈥痑nd鈥疘nHealth Ventures also participating.聽
It takes the total鈥痑mount鈥痳aised鈥痶o date鈥痓y鈥疕eydoc鈥痶o $12m, with the bulk of the new raise used to grow its team, which currently stands at 30 employees.聽
鈥淲e鈥檙e very excited to have Smedvig Capital as a partner in this new chapter of our adventure,鈥� said co-founder and CEO Christoph鈥疞ippuner.聽
鈥淭his new raise will help us accelerate our growth in the UK, focus on our product and expand its capabilities, as well as go after international markets. Innovating and contributing to a transforming healthcare industry, profoundly impacted by regulatory changes, new patient expectations and a global pandemic, is both fascinating and rewarding.聽
鈥淭here is so much to be done in this industry and Heydoc is barely scratching the surface.鈥�
/blog/2021/09/30/healthtech-cera-to-create-5000-new-jobs/
Heydoc鈥檚鈥痬ission is to improve healthcare鈥痓y empowering clinical teams鈥痺ith an all-encompassing operating system. Its software solves core workflow issues鈥痜or clinicians, providing a full suite of features covering both medical and administrative tasks.聽
Heydoc also connects its clinic customers with various other healthcare providers – such as hospital groups, pathology services and pharmacies – ensuring data liquidity and tackling a major challenge in healthcare, the lack of systems interoperability.鈥��
Since going live in 2018, it has鈥痝ained rapid鈥痶raction through鈥痺ord-of-mouth鈥痳eferrals and now serve thousands of clinicians and administrative staff across the UK.鈥��
Jon Lerner, MD at Smedvig Capital, added: 鈥淲e are delighted to invest in Heydoc and partner with Christoph and Mikael.聽
鈥淗eydoc has grown rapidly and proven that its platform can dramatically improve the way clinicians work and the quality of patient interaction.聽
鈥淭he company has a strong mission-based culture and a huge opportunity in front of them to be part of the future of healthcare. We鈥檙e looking forward to supporting them in achieving this goal.鈥�